Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | hSTC810 |
Synonyms | |
Therapy Description |
hSTC810 is an antibody that targets BTN1A1, which potentially inhibits tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 5318). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
hSTC810 | Immune Checkpoint Inhibitor 149 | hSTC810 is an antibody that targets BTN1A1, which potentially inhibits tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 5318). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05231746 | Phase I | hSTC810 | A Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001) | Completed | USA | 1 |